The anti-cancer effect of EHMT2 inhibition has been studied in several cancer cell lines in primary cells of breast cancer, neuroblastoma, colon, and bladder cancer [12,29,30], suggesting possible therapeutic options for cancer treatment. This evidence concerns the gene EHMT2 and urinary bladder carcinoma.